Boothbay Fund Management’s MacroGenics MGNX Stock Holding History

Boothbay Fund Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-139,400	Closed	-$2.05M	–	1740
2024 Q1	$2.05M	Buy	+139,400	New	+$2.11M	0.04%	500
2021 Q4	–	Sell	-44,900	Closed	-$940K	–	2088
2021 Q3	$940K	Buy	44,900 +11,100	+33%	+$267K	0.03%	795
2021 Q2	$908K	Buy	33,800 +33,576	+14,989%	+$983K	0.03%	746
2021 Q1	$713K	Buy	+224	New	+$5.44K	0.03%	758
2020 Q1	–	Sell	-263	Closed	-$286K	–	977
2019 Q4	$286K	Hold	263	–	–	0.02%	610
2019 Q3	$336K	Buy	+263	New	+$3.79K	0.03%	554

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Boothbay Fund Management's MGNX Position: Q1 2026 in Review

Boothbay Fund Management held its MacroGenics (MGNX) position steady in Q1 2026 at 18,334 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Boothbay Fund Management first reported a position in MGNX in Q1 2020 and has held it in 16 quarters since. The position peaked at $1.93M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Boothbay Fund Management held 18,334 shares of MacroGenics worth $53K as of Q1 2026.
Boothbay Fund Management left its MacroGenics share count unchanged in Q1 2026.
MacroGenics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1923 holding.
Boothbay Fund Management first reported a position in MacroGenics in Q1 2020 and has held it in 16 quarters since.
Boothbay Fund Management's MacroGenics position peaked at $1.93M in Q1 2021.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.